FDA Approved First Medication for Obstructive Sleep Apnea
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…
Obstructive sleep apnea associated with increased risks for long COVID
On May 11, 2023, a National Institutes of Health supported long-term study reported that among people who have…
U.S. Preventive Services Task Force issued recommendation on screening for obstructive sleep apnea in adults
On Nov. 15, 2022, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…